Evercore ISI analyst Elizabeth Anderson raised the agency’s value goal on Charles River (CRL) to $200 from $190 and retains an Outperform score on the shares. The agency’s survey work factors to a optimistic outlook for preclinical CROs, with rising budgets and declining cancellations, together with suggesting secure demand for discovery and toxicology providers into 2025 and 2026, the analyst tells traders in a word on the group.
-
Make the most of TipRanks Premium at 55% off! Unlock highly effective investing instruments, superior knowledge, and skilled analyst insights that can assist you make investments with confidence.
Printed first on TheFly – the final word supply for real-time, market-moving breaking monetary information. Strive Now>>
See as we speak’s best-performing shares on TipRanks >>
Learn Extra on CRL:
Disclaimer & DisclosureReport an Situation